Release Date: 12/10/16 11:55 Summary: Appendix 3B - Dividend Reinvestment Plan-DSB.AX Price Sensitive: No Download Document 749.99KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status